| Name | Title | Contact Details |
|---|
Retire-At-Home Services Inc is a Ottawa, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
New England Institutional Review Board NEIRB is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias. We have created a unique platform, ZIO by iRhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.
Openfit is the place to go to get results and have fun doing it – an all-new digital streaming platform that integrates fitness, nutrition, and wellness together in one place. We offer world-class fitness programs with workouts designed to reach any goal, perfectly paired nutrition plans, safe and effective supplements, and customized wellness advice. In the process, we`ve searched far and wide to bring together the world`s foremost fitness and nutrition experts to make sure you succeed in reaching your goals. Whether you`re training for an extreme event, looking to lose weight, or just wanting to live each day a little healthier than the last – you`ll not only find solutions at Openfit, you`ll find inspiration. The kind that powers you through your workout and leaves you feeling pumped to do it again tomorrow. So you can reach your goals…and want to come back for more. That`s the simplicity of living a healthy, vibrant life – in your own way – every day. We hope you`ll come live yours at Openfit.
Cynvenio is a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood.